Innovative injection moulding technology in the latest addition of the uvex pheos family delivers outstanding protection, wearer comfort and workplace compliance.
The new generation uvex pheos cx2 is set to take uvex’s bestselling spectacle to the next level. The X-tended eye shield and brow guard with injection moulded, soft component technology resulting in a close fit to the face provides reliable protection against minor splashes of relatively innocuous chemicals where the risk has been evaluated as acceptably low splash and particle ingress.
The four-point frame check ensures the eye protector fits wearer’s perfectly to deliver reliable protection. The distinctive design and shape of the side arms together with the innovative X-Twist technology allows the uvex pheos cx2 to adapt to individual wearer providing a customised, comfortable fit. The uvex pheos cx2 also scores highly from a fit perspective. The distance between the forehead and spectacles is measured at four different points to ensure the ultimate fit. Providing a spectacle with outstanding ergonomic features.
As a successful global equipment provider to top performing athletes, the trust they place in the uvex brand demonstrates the importance of the appropriate protective equipment for achieving personal best no matter how strenuous the activity is. As in sport, the industrial workplace also presents daily challenges for management, workers and protective equipment. With the uvex pheos cx2 be safe in the knowledge that your PPE will perform at the crucial moment, and that you are using ‘equipment of champions’.
Be the first to try our NEW safety glasses! available August 2017. Request your free sample: https://uvexsafety.com.au/pheoscx2/
Our mission is ‘protecting people’. Our goal is to work with you together to help reduce injuries and lower your PPE costs. Work directly with your Uvex specialist to recommend and implement high performance site PPE solutions. Contact our customer service for your trial on 1800 815 790 or email email@example.com.